rs2159116
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000135.4(FANCA):c.2602-36G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 1,610,760 control chromosomes in the GnomAD database, including 22,894 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1477 hom., cov: 33)
Exomes 𝑓: 0.16 ( 21417 hom. )
Consequence
FANCA
NM_000135.4 intron
NM_000135.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.70
Publications
23 publications found
Genes affected
FANCA (HGNC:3582): (FA complementation group A) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008]
FANCA Gene-Disease associations (from GenCC):
- Fanconi anemia complementation group AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-89765102-C-A is Benign according to our data. Variant chr16-89765102-C-A is described in ClinVar as Benign. ClinVar VariationId is 255248.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.17 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FANCA | ENST00000389301.8 | c.2602-36G>T | intron_variant | Intron 27 of 42 | 1 | NM_000135.4 | ENSP00000373952.3 |
Frequencies
GnomAD3 genomes AF: 0.122 AC: 18621AN: 152126Hom.: 1477 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
18621
AN:
152126
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.145 AC: 36116AN: 248354 AF XY: 0.153 show subpopulations
GnomAD2 exomes
AF:
AC:
36116
AN:
248354
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.165 AC: 240568AN: 1458516Hom.: 21417 Cov.: 32 AF XY: 0.167 AC XY: 120937AN XY: 725560 show subpopulations
GnomAD4 exome
AF:
AC:
240568
AN:
1458516
Hom.:
Cov.:
32
AF XY:
AC XY:
120937
AN XY:
725560
show subpopulations
African (AFR)
AF:
AC:
1195
AN:
33414
American (AMR)
AF:
AC:
4614
AN:
44498
Ashkenazi Jewish (ASJ)
AF:
AC:
4795
AN:
26090
East Asian (EAS)
AF:
AC:
72
AN:
39636
South Asian (SAS)
AF:
AC:
16074
AN:
85876
European-Finnish (FIN)
AF:
AC:
7752
AN:
53132
Middle Eastern (MID)
AF:
AC:
1591
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
195043
AN:
1109876
Other (OTH)
AF:
AC:
9432
AN:
60228
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
9878
19756
29635
39513
49391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6710
13420
20130
26840
33550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.122 AC: 18611AN: 152244Hom.: 1477 Cov.: 33 AF XY: 0.120 AC XY: 8952AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
18611
AN:
152244
Hom.:
Cov.:
33
AF XY:
AC XY:
8952
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
1580
AN:
41556
American (AMR)
AF:
AC:
1854
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
603
AN:
3468
East Asian (EAS)
AF:
AC:
23
AN:
5184
South Asian (SAS)
AF:
AC:
826
AN:
4820
European-Finnish (FIN)
AF:
AC:
1427
AN:
10604
Middle Eastern (MID)
AF:
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
AC:
11742
AN:
67994
Other (OTH)
AF:
AC:
317
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
846
1692
2538
3384
4230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
320
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Fanconi anemia complementation group A Benign:2
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 08, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.